Role of rosiglitazone in lipopolysaccharide-induced peritonitis: A rat peritoneal dialysis model

被引:7
|
作者
Song, Sang Heon [1 ,2 ]
Kwak, Ihm Soo [1 ,2 ]
Yang, Byeong Yun [1 ,2 ]
Lee, Dong Won [1 ,2 ]
Lee, Soo Bong [1 ,2 ]
Lee, Min Young [2 ]
机构
[1] Pusan Natl Univ Hosp, Dept Internal Med, Pusan 602739, South Korea
[2] Pusan Natl Univ Hosp, Med Res Inst, Pusan 602739, South Korea
关键词
peritoneal dialysis; peritonitis; peroxisome proliferator-activated receptor-gamma; ACTIVATED-RECEPTOR-GAMMA; PPAR-GAMMA; MESOTHELIAL CELLS; DOWN-REGULATION; EXPRESSION; ALPHA; DIFFERENTIATION; AGONIST; DISEASE; INJURY;
D O I
10.1111/j.1440-1797.2008.01037.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Aim: The aim of this study was to demonstrate the efficacy of the peroxisome proliferator-activated receptor (PPAR)-gamma agonist, rosiglitazone, in the amelioration or prevention of inflammation including peritoneal fibrosis secondary to the peritonitis in a peritoneal dialysis (PD) model of non-uraemic rats. Methods: Thirty male Sprague-Dawley rats were assigned to six groups according to treatment. A 90 min peritoneal equilibrium test, dialysate cellular components, peritoneal thickness and cellularity were assessed on day 21. Additionally, immunohistochemical stains of peritoneal membrane, such as PPAR-gamma, vascular endothelial growth factor (VEGF), transforming growth factor (TGF)-beta 1, collagen-1 and monocyte chemoattractant protein-1 were performed Results: The dialysate neutrophil count and peritoneal thickness in the high-dose rosiglitazone group was significantly decreased compared to the lipopolysaccharide (LPS)-only group. The peritoneal membrane from the LPS-only group showed marked cellular proliferation in the area of the submesothelial compact zone compared with the PD-only group, the rosiglitazone-only group, and the high-dose rosiglitazone group. The 90 min peritoneal equilibrium test (PET) results showed no statistical difference among the six groups excluding dialysate-to-plasma urea ratio. The number of PPAR-gamma expressing cells and the expression of TGF-beta 1 were decreased in the high-dose rosiglitazone group compared to the LPS-only group. There were no differences in the expression of VEGF and collagen-1 among the six groups. Interestingly, the number of PPAR-gamma-positive cells was correlated with expression of VEGF, TGF-beta 1, collagen-1 and monocyte chemoattractant protein-1 irrespective of the study group. Conclusion: The results of this study showed that rosiglitazone ameliorated peritoneal inflammation induced by LPS and reduced the TGF-beta 1 expression in the peritoneal membranes.
引用
收藏
页码:155 / 163
页数:9
相关论文
共 50 条
  • [1] Prevention of lipopolysaccharide-induced peritoneal damage by eplerenone in rats undergoing peritoneal dialysis
    Tayama, Yosuke
    Hasegawa, Hajime
    Takayanagi, Kaori
    Matsuda, Akihiko
    Shimizu, Taisuke
    Asakura, Juko
    Iwashita, Takatsugu
    Ogawa, Tomonari
    Katoh, Hitoshi
    Mitarai, Tetsuya
    JOURNAL OF NEPHROLOGY, 2013, 26 (06) : 1160 - 1169
  • [2] Lipopolysaccharide Evaluation in Peritoneal Dialysis Patients with Peritonitis
    Manani, Sabrina Milan
    Virz, Grazia Maria
    Giuliani, Anna
    Baretta, Michele
    Corradi, Valentina
    De Cal, Massimo
    Biasi, Caterina
    Crepaldi, Carlo
    Ronco, Claudio
    BLOOD PURIFICATION, 2020, 49 (04) : 434 - 439
  • [3] Inhibitory Effects of Rosiglitazone on Lipopolysaccharide-Induced Inflammation in a Murine Model and HK-2 Cells
    Wang, W. M.
    Chen, H.
    Zhong, F.
    Lu, Y.
    Han, L.
    Chen, N.
    AMERICAN JOURNAL OF NEPHROLOGY, 2011, 34 (02) : 152 - 162
  • [4] Rosiglitazone, a Peroxisome Proliferator-Activated Receptor (PPAR)-γ Agonist, Attenuates Inflammation Via NF-κB Inhibition in Lipopolysaccharide-Induced Peritonitis
    Zhang, Yun-Fang
    Zou, Xun-Liang
    Wu, Jun
    Yu, Xue-Qing
    Yang, Xiao
    INFLAMMATION, 2015, 38 (06) : 2105 - 2115
  • [5] Transcriptomics Changes in the Peritoneum of Mice with Lipopolysaccharide-Induced Peritonitis
    Liu, Shaoguang
    Zhang, Shaotong
    Sun, Yulong
    Zhou, Wence
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (23)
  • [6] A microrna screen to identify regulators of peritoneal fibrosis in a rat model of peritoneal dialysis
    Lin, Fan
    Wu, Xu
    Zhang, Huidi
    You, Xiaohan
    Zhang, Zhoucang
    Shao, Rongrong
    Huang, Chaoxing
    BMC NEPHROLOGY, 2015, 16
  • [7] Diagnostic and prognostic role of peritoneal CA 125 in peritoneal dialysis patients presenting with acute peritonitis
    Panorchan, Kwanpeemai
    Davenport, Andrew
    BMC NEPHROLOGY, 2014, 15
  • [8] Rosiglitazone inhibits lipopolysaccharide-induced A549 cell apoptosis and inflammation
    Lu, Xiaoxian
    Luo, Liang
    Ji, Xiaoxia
    Li, Qianqian
    Bao, Jie
    Song, Yong
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (03): : 1855 - 1863
  • [9] Rosiglitazone pretreatment protects against lipopolysaccharide-induced fetal demise through inhibiting placental inflammation
    Bo, Qing-Li
    Chen, Yuan-Hua
    Yu, Zhen
    Fu, Lin
    Zhou, Yan
    Zhang, Gui-Bin
    Wang, Hua
    Zhang, Zhi-Hui
    Xu, De-Xiang
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2016, 423 (0C) : 51 - 59
  • [10] Oxalate Balance in Peritoneal Dialysis Patients: A Potential Role of Dialysis-related Peritonitis
    Stepanova, Natalia
    Korol, Lesya
    Lebid, Larysa
    Snisar, Lyudmyla
    Savchenko, Svitlana
    IN VIVO, 2022, 36 (02): : 925 - 933